- Home
- Publications
- Publication Search
- Publication Details
Title
Genetic lesions in diffuse large B-cell lymphomas
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 26, Issue 6, Pages 1069-1080
Publisher
Oxford University Press (OUP)
Online
2015-01-21
DOI
10.1093/annonc/mdv019
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Guidelines for NHL: Updates to the Management of Diffuse Large B-Cell Lymphoma and New Guidelines for Primary Cutaneous CD30+ T-Cell Lymphoproliferative Disorders and T-Cell Large Granular Lymphocytic Leukemia
- (2017) Andrew D. Zelenetz Journal of the National Comprehensive Cancer Network
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recurrent targets of aberrant somatic hypermutation in lymphoma
- (2015) Alireza Hadj Khodabakhshi et al. Oncotarget
- Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis
- (2014) A. M. Petrich et al. BLOOD
- MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab
- (2014) Anamarija M. Perry et al. BRITISH JOURNAL OF HAEMATOLOGY
- Double hit lymphoma: the MD Anderson Cancer Center clinical experience
- (2014) Yasuhiro Oki et al. BRITISH JOURNAL OF HAEMATOLOGY
- Evaluating Cell-of-Origin Subtype Methods for Predicting Diffuse Large B-Cell Lymphoma Survival: A Meta-Analysis of Gene Expression Profiling and Immunohistochemistry Algorithms
- (2014) Jay A. Read et al. Clinical Lymphoma Myeloma & Leukemia
- BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma
- (2014) Samantha L. Kendrick et al. HUMAN PATHOLOGY
- Genetics of Follicular Lymphoma Transformation
- (2014) Laura Pasqualucci et al. Cell Reports
- Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma
- (2013) A. Bouska et al. BLOOD
- Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma
- (2013) P. Bonetti et al. BLOOD
- Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome
- (2013) E. Chigrinova et al. BLOOD
- MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
- (2013) H. Horn et al. BLOOD
- Analysis of FOXO1 mutations in diffuse large B-cell lymphoma
- (2013) D. L. Trinh et al. BLOOD
- I B- controls the constitutive NF- B target gene network and survival of ABC DLBCL
- (2013) H. Nogai et al. BLOOD
- Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing
- (2013) R. D. Morin et al. BLOOD
- Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome
- (2013) Giulia Fabbri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- MYC rearrangements are useful for predicting outcomes following rituximab and chemotherapy: multicenter analysis of Japanese patients with diffuse large B-cell lymphoma
- (2013) Minoru Kojima et al. LEUKEMIA & LYMPHOMA
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma
- (2013) Carol Y Ying et al. NATURE IMMUNOLOGY
- Genetic heterogeneity of diffuse large B-cell lymphoma
- (2013) Jenny Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma
- (2013) M. Pfeifer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)
- (2012) M. Ghielmini et al. ANNALS OF ONCOLOGY
- Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study
- (2012) L. de Leval et al. ANNALS OF ONCOLOGY
- Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma
- (2012) W. Klapper et al. BLOOD
- MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation
- (2012) W. Cuccuini et al. BLOOD
- Metabolic Signatures Uncover Distinct Targets in Molecular Subsets of Diffuse Large B Cell Lymphoma
- (2012) Pilar Caro et al. CANCER CELL
- Integrative Analysis Reveals an Outcome-Associated and Targetable Pattern of p53 and Cell Cycle Deregulation in Diffuse Large B Cell Lymphoma
- (2012) Stefano Monti et al. CANCER CELL
- Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study
- (2012) C. Visco et al. HAEMATOLOGICA
- Double-Hit Diffuse Large B-Cell Lymphoma
- (2012) Jonathan W. Friedberg JOURNAL OF CLINICAL ONCOLOGY
- Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
- (2012) Tina Marie Green et al. JOURNAL OF CLINICAL ONCOLOGY
- Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
- (2012) Nathalie A. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- BCL6 positively regulates AID and germinal center gene expression via repression of miR-155
- (2012) Katia Basso et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
- (2012) C Visco et al. LEUKEMIA
- EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
- (2012) Michael T. McCabe et al. NATURE
- Immunohistochemical Detection of MYC-driven Diffuse Large B-Cell Lymphomas
- (2012) Michael J. Kluk et al. PLoS One
- Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)
- (2012) M. T. McCabe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNAs miR-125a and miR-125b constitutively activate the NF- B pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20)
- (2012) S.-W. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation
- (2012) W. Qi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
- (2012) J. G. Lohr et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion
- (2011) M. Mian et al. ANNALS OF ONCOLOGY
- Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma
- (2011) S. T. Wilkinson et al. BLOOD
- The molecular pathogenesis of primary mediastinal large B-cell lymphoma
- (2011) C. Steidl et al. BLOOD
- Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
- (2011) G. Gutierrez-Garcia et al. BLOOD
- Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults
- (2011) I. Salaverria et al. BLOOD
- Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expression
- (2011) Joshua D. Schiffman et al. BRITISH JOURNAL OF HAEMATOLOGY
- Integrated profiling of diffuse large B-cell lymphoma with 7q gain
- (2011) Ekaterina Chigrinova et al. BRITISH JOURNAL OF HAEMATOLOGY
- Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP
- (2011) Monica Testoni et al. BRITISH JOURNAL OF HAEMATOLOGY
- Prognostic significance ofMYC,BCL2, andBCL6rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab
- (2011) Nalan Akyurek et al. CANCER
- Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell Lymphoma
- (2011) Madhavi Challa-Malladi et al. CANCER CELL
- STAT3 Inhibition Is a Therapeutic Strategy for ABC-like Diffuse Large B-Cell Lymphoma
- (2011) A. Scuto et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- BCL2 Predicts Survival in Germinal Center B-cell-like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab
- (2011) J. Iqbal et al. CLINICAL CANCER RESEARCH
- The Y641C mutation of EZH2 alters substrate specificity for histone H3 lysine 27 methylation states
- (2011) Tim J. Wigle et al. FEBS LETTERS
- Clinical significance and prognosis of MYC translocation in diffuse large B-cell lymphoma
- (2011) Hong Wei Zhang et al. HEMATOLOGICAL ONCOLOGY
- Immunohistochemical detection of MYC protein correlates with MYC gene status in aggressive B cell lymphomas
- (2011) Gustavo Tapia et al. HISTOPATHOLOGY
- The Gray Zone Between Burkitt's Lymphoma and Diffuse Large B-Cell Lymphoma From a Genetics Perspective
- (2011) Itziar Salaverria et al. JOURNAL OF CLINICAL ONCOLOGY
- The Germinal Center/Activated B-Cell Subclassification Has a Prognostic Impact for Response to Salvage Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Bio-CORAL Study
- (2011) Catherine Thieblemont et al. JOURNAL OF CLINICAL ONCOLOGY
- BCL2 mutations in diffuse large B-cell lymphoma
- (2011) J M Schuetz et al. LEUKEMIA
- The miRNA-17∼92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation
- (2011) E Rao et al. LEUKEMIA
- B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome
- (2011) Shaoying Li et al. MODERN PATHOLOGY
- Inactivating mutations of acetyltransferase genes in B-cell lymphoma
- (2011) Laura Pasqualucci et al. NATURE
- Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
- (2011) Ryan D. Morin et al. NATURE
- MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
- (2011) Christian Steidl et al. NATURE
- Analysis of the coding genome of diffuse large B-cell lymphoma
- (2011) Laura Pasqualucci et al. NATURE GENETICS
- EZH2 Codon 641 Mutations are Common in BCL2-Rearranged Germinal Center B Cell Lymphomas
- (2011) Russell J. H. Ryan et al. PLoS One
- Molecular pathogenesis of diffuse large B-cell lymphoma
- (2011) Christof Schneider et al. SEMINARS IN DIAGNOSTIC PATHOLOGY
- B-cell Lymphomas With Concurrent IGH-BCL2 and MYC Rearrangements Are Aggressive Neoplasms With Clinical and Pathologic Features Distinct From Burkitt Lymphoma and Diffuse Large B-cell Lymphoma
- (2010) Matija Snuderl et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation
- (2010) D. B. Yap et al. BLOOD
- Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL
- (2010) G. Ott et al. BLOOD
- Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study
- (2010) F. Jardin et al. BLOOD
- Double-hit B-cell lymphomas
- (2010) S. M. Aukema et al. BLOOD
- Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma
- (2010) Andrea Rinaldi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21
- (2010) Marta Scandurra et al. BRITISH JOURNAL OF HAEMATOLOGY
- Advances in the understanding of MYC-induced lymphomagenesis
- (2010) Kay Klapproth et al. BRITISH JOURNAL OF HAEMATOLOGY
- Constitutive Canonical NF-κB Activation Cooperates with Disruption of BLIMP1 in the Pathogenesis of Activated B Cell-like Diffuse Large Cell Lymphoma
- (2010) Dinis Pedro Calado et al. CANCER CELL
- BLIMP1 Is a Tumor Suppressor Gene Frequently Disrupted in Activated B Cell-like Diffuse Large B Cell Lymphoma
- (2010) Jonathan Mandelbaum et al. CANCER CELL
- Acquired TNFRSF14 Mutations in Follicular Lymphoma Are Associated with Worse Prognosis
- (2010) K.-J. J. Cheung et al. CANCER RESEARCH
- Spectrum of HIV lymphoma 2009
- (2010) Ayca Gucalp et al. CURRENT OPINION IN HEMATOLOGY
- Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma
- (2010) C. J. Stasik et al. HAEMATOLOGICA
- Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome
- (2010) Ekaterina Chigrinova et al. HEMATOLOGICAL ONCOLOGY
- Rearrangement ofMYCIs Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab
- (2010) Sharon Barrans et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunohistochemical Methods for Predicting Cell of Origin and Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab
- (2010) Paul N. Meyer et al. JOURNAL OF CLINICAL ONCOLOGY
- Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV
- (2010) Sarah T. Wilkinson et al. LEUKEMIA & LYMPHOMA
- Oncogenically active MYD88 mutations in human lymphoma
- (2010) Vu N. Ngo et al. NATURE
- Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
- (2010) R. Eric Davis et al. NATURE
- Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
- (2010) Ryan D Morin et al. NATURE GENETICS
- Aggressive Lymphomas
- (2010) Georg Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival
- (2009) N. A. Johnson et al. BLOOD
- BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt
- (2009) P. Juszczynski et al. BLOOD
- MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy
- (2009) K. J. Savage et al. BLOOD
- Genome wide DNA-profiling of HIV-related B-cell lymphomas
- (2009) Daniela Capello et al. BRITISH JOURNAL OF HAEMATOLOGY
- A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy
- (2009) W. W.L. Choi et al. CLINICAL CANCER RESEARCH
- CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression
- (2009) L. M. Rimsza et al. HAEMATOLOGICA
- Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP
- (2009) J. Shustik et al. HAEMATOLOGICA
- Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas
- (2009) Marta Scandurra et al. HEMATOLOGICAL ONCOLOGY
- Richter syndrome: molecular insights and clinical perspectives
- (2009) Davide Rossi et al. HEMATOLOGICAL ONCOLOGY
- Immuno–Fluorescence In Situ Hybridization Index Predicts Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP: A GELA Study
- (2009) Christiane Copie-Bergman et al. JOURNAL OF CLINICAL ONCOLOGY
- Predicting transformation in follicular lymphoma
- (2009) Daphne de Jong et al. LEUKEMIA & LYMPHOMA
- Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
- (2009) Mara Compagno et al. NATURE
- Frequent inactivation of A20 in B-cell lymphomas
- (2009) Motohiro Kato et al. NATURE
- COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer
- (2009) Simon A. Forbes et al. NUCLEIC ACIDS RESEARCH
- BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma
- (2009) M. Saito et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes
- (2008) M. Inomata et al. BLOOD
- Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas
- (2008) R. Malumbres et al. BLOOD
- miRiad Roles for the miR-17-92 Cluster in Development and Disease
- (2008) Joshua T. Mendell CELL
- Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL)
- (2008) Kelly A. Cycon et al. EXPERIMENTAL HEMATOLOGY
- Retracted: Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)
- (2008) D. de Jong et al. JOURNAL OF CLINICAL PATHOLOGY
- Stromal Gene Signatures in Large-B-Cell Lymphomas
- (2008) G. Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
- (2008) G. Lenz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma
- (2008) G. Lenz et al. SCIENCE
- LMO2 Protein Expression Predicts Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy With and Without Rituximab
- (2007) Yasodha Natkunam et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More